ProfileGDS4718 / 209196_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 72% 74% 74% 72% 87% 88% 76% 71% 79% 79% 70% 84% 87% 85% 79% 78% 85% 84% 67% 79% 76% 76% 77% 77% 86% 75% 83% 74% 81% 80% 83% 73% 75% 86% 85% 85% 77% 74% 76% 77% 84% 78% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4263676
GSM549102patient 115, normal, homogenized [OPG study]6.9771872
GSM549104patient 119, normal, homogenized [OPG study]7.3141874
GSM549108patient 138, normal, homogenized [OPG study]7.1555874
GSM549119patient 077, normal, homogenized [OPG study]6.9879372
GSM549133patient 032, cancer, homogenized [OPG study]8.8540987
GSM549139patient 042, cancer, homogenized [OPG study]8.9199888
GSM549099patient 107, normal, homogenized [OPG study]7.3235276
GSM549109patient 139, normal, homogenized [OPG study]6.9188671
GSM549110patient 046, normal, homogenized [OPG study]7.6937279
GSM549114patient 063, normal, homogenized [OPG study]7.8124379
GSM549122patient 082, normal, homogenized [OPG study]6.8617970
GSM549134patient 033, cancer, homogenized [OPG study]8.3149784
GSM549136patient 036, cancer, homogenized [OPG study]8.8752787
GSM549140patient 044, cancer, homogenized [OPG study]8.5772185
GSM549111patient 047, normal, homogenized [OPG study]7.829279
GSM549113patient 057, normal, homogenized [OPG study]7.7533278
GSM549132patient 031, cancer, homogenized [OPG study]8.5125785
GSM549137patient 038, cancer, homogenized [OPG study]8.3707184
GSM549142patient 047, cancer, homogenized [OPG study]6.6509867
GSM549100patient 110, normal, homogenized [OPG study]7.6133179
GSM549107patient 135, normal, homogenized [OPG study]7.4480376
GSM549115patient 068, normal, homogenized [OPG study]7.5564476
GSM549116patient 072, normal, homogenized [OPG study]7.5315577
GSM549120patient 078, normal, homogenized [OPG study]7.5116177
GSM549131patient 030, cancer, homogenized [OPG study]8.6336586
GSM549118patient 074, normal, homogenized [OPG study]7.3560975
GSM549129patient 027, cancer, homogenized [OPG study]8.2280683
GSM549123patient 088, normal, homogenized [OPG study]7.2132274
GSM549124patient 006, cancer, homogenized [OPG study]7.9020581
GSM549126patient 015, cancer, homogenized [OPG study]7.8289180
GSM549128patient 025, cancer, homogenized [OPG study]8.2981983
GSM549103patient 117, normal, homogenized [OPG study]7.0518473
GSM549117patient 073, normal, homogenized [OPG study]7.3489875
GSM549138patient 041, cancer, homogenized [OPG study]8.6257186
GSM549141patient 045, cancer, homogenized [OPG study]8.5211885
GSM549130patient 028, cancer, homogenized [OPG study]8.3377685
GSM549101patient 111, normal, homogenized [OPG study]7.5266777
GSM549105patient 128, normal, homogenized [OPG study]7.1735174
GSM549106patient 134, normal, homogenized [OPG study]7.6162676
GSM549112patient 048, normal, homogenized [OPG study]7.5564377
GSM549125patient 011, cancer, homogenized [OPG study]8.3153184
GSM549127patient 024, cancer, homogenized [OPG study]7.6986578
GSM549135patient 035, cancer, homogenized [OPG study]9.0801589